Novacyt announced that David Allmond is stepping down as a member of the Board of Novacyt, with immediate effect, to enable him to pursue other business opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.819 EUR | +2.89% | -1.33% | +14.87% |
Apr. 19 | Novacyt: confident ahead of DHSC trial | CF |
Apr. 19 | Novacyt expects court to dismiss application by UK DHSC | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.87% | 60.15M | |
-28.51% | 922M | |
-20.60% | 129M | |
-7.82% | 61.39M | |
+6.64% | 60.85M | |
+0.60% | 51.57M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt Announces Step Down of David Allmond as Member of the Board